These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31974139

  • 1. Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes.
    Jörns A, Wedekind D, Jähne J, Lenzen S.
    Diabetes; 2020 Apr; 69(4):624-633. PubMed ID: 31974139
    [Abstract] [Full Text] [Related]

  • 2. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with β-cell autoantigens.
    Badal D, Kumar R, Paul M, Dayal D, Bhansali A, Bhadada SK, Kumar R, Sachdeva N.
    Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
    [Abstract] [Full Text] [Related]

  • 3. Innate immunity in latent autoimmune diabetes in adults.
    Huang J, Pearson JA, Wong FS, Wen L, Zhou Z.
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3480. PubMed ID: 34156143
    [Abstract] [Full Text] [Related]

  • 4. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.
    Jörns A, Arndt T, Meyer zu Vilsendorf A, Klempnauer J, Wedekind D, Hedrich HJ, Marselli L, Marchetti P, Harada N, Nakaya Y, Wang GS, Scott FW, Gysemans C, Mathieu C, Lenzen S.
    Diabetologia; 2014 Mar; 57(3):512-21. PubMed ID: 24310561
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults.
    Lu J, Hou X, Pang C, Zhang L, Hu C, Zhao J, Bao Y, Jia W.
    Diabetes Metab Res Rev; 2016 Nov; 32(8):858-866. PubMed ID: 27037998
    [Abstract] [Full Text] [Related]

  • 6. Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 Diabetes, and Type 2 Diabetes.
    Castelblanco E, Hernández M, Castelblanco A, Gratacòs M, Esquerda A, Molló À, Ramírez-Morros A, Real J, Franch-Nadal J, Fernández-Real JM, Mauricio D.
    Diabetes Care; 2018 Apr; 41(4):862-868. PubMed ID: 29358494
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development.
    Siewko K, Maciulewski R, Zielinska-Maciulewska A, Poplawska-Kita A, Szumowski P, Wawrusiewicz-Kurylonek N, Lipinska D, Milewski R, Gorska M, Kretowski A, Szelachowska M.
    Biomed Res Int; 2019 Apr; 2019():4734063. PubMed ID: 31772933
    [Abstract] [Full Text] [Related]

  • 8. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
    Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD.
    Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmunity-Associated PTPN22 Polymorphisms in Latent Autoimmune Diabetes of the Adult Differ from Those of Type 1 Diabetes Patients.
    Heneberg P, Kocková L, Čecháková M, Daňková P, Černá M.
    Int Arch Allergy Immunol; 2018 Oct; 177(1):57-68. PubMed ID: 29895027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of common type 1 and type 2 diabetes gene variants with latent autoimmune diabetes in adults: A meta-analysis.
    Ramu D, Perumal V, Paul SFD.
    J Diabetes; 2019 Jun; 11(6):484-496. PubMed ID: 30456822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.
    Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC, Action LADA Study Group.
    Diabetologia; 2011 Jul; 54(7):1630-8. PubMed ID: 21347621
    [Abstract] [Full Text] [Related]

  • 18. Boswellic extracts and 11-keto-ß-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines.
    Ammon HPT.
    Phytomedicine; 2019 Oct; 63():153002. PubMed ID: 31301539
    [Abstract] [Full Text] [Related]

  • 19. Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes.
    Singh K, Martinell M, Luo Z, Espes D, Stålhammar J, Sandler S, Carlsson PO.
    Clin Exp Immunol; 2019 Jul; 197(1):64-73. PubMed ID: 30843600
    [Abstract] [Full Text] [Related]

  • 20. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.
    Orv Hetil; 2001 Nov 18; 142(46):2571-8. PubMed ID: 11770176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.